key: cord-0776995-xcsf4b6o
authors: Rossato, Marco; Vincenzo, Angelo Di; Vettor, Roberto
title: COVID-19 and Smoking: An Opportunity to Quit… When Vaccinated!
date: 2021-05-21
journal: Arch Bronconeumol
DOI: 10.1016/j.arbres.2021.05.003
sha: 7c69c9a5c22d5d23f126da9458078fdb84baa346
doc_id: 776995
cord_uid: xcsf4b6o

nan

We have read with interest the article by Pastor Esplà et al. and we agree with the authors that smoking is a risk factor for severe clinical course of COVID-19. 1 To this respect we have also to consider that among patients hospitalized for SARS-CoV-2 related pneumonia, the prevalence of active smokers is very low, whatever the country we consider, from China to Europe and United States of America. 2, 3 There is a critical difference between the role of smoking (current/former) in the severe outcomes in COVID-19 and the quite low prevalence of active smokers among patients hospitalized for COVID-19. This is a very important clue since in the first case we all agree that smokers have more severe outcomes in COVID-19 probably due to the many comorbidities affecting smokers (active/former). In the second case, i.e. the low prevalence of current smokers among patients hospitalized for COVID-19, the main point is that current smoking seem to be "protective" towards the SARS-CoV-2 induced severe clinical complications.

To this respect there are data showing that among COVID-19 patients, significantly more former smokers were hospitalized and died from COVID-19 than current or never smokers. 4 Thus there is the need to understand the possible mechanisms allowing cigarette smoking to dampen the inflammatory response during infection by SARS-CoV-2 strongly reducing the severe complications of SARS-CoV-2 infection, mainly interstitial pneumonia and ARDS. 5 Thus, we fully agree with Pastor Esplà et al. in considering each occasion as a useful opportunity to quit smoking, 1 thus reducing its well known unhealthy consequences. But considering the present SARS-CoV-2 pandemy, the lack of effective pharmacological treatments, and the reported 'protective' effects of active smoking towards severe COVID-19 complications, smoke cessation in current smokers could be suggested after SARS-CoV-2 vaccination! 

Chiner Vives E. COVID-19 and smoking: an opportunity to quit

Current smoking is not associated with COVID-19

A systematic review and meta-analysis of hospitalised current smokers and COVID-19

Smoking and risk of COVID-19 hospitalization

Cigarette smoking and COVID-19. Pulmonology